Aprea Therapeutics Inc (APRE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Sales | 163 | 206 | 355 | 562 | 381 |
| Gross Profit | 163 | 206 | 355 | 562 | 381 |
| Operating Expenses | 4,248 | 3,432 | 4,452 | 4,409 | 3,530 |
| Operating Income | -4,086 | -3,226 | -4,097 | -3,847 | -3,150 |
| Other Income | 153 | 331 | 313 | 377 | 340 |
| Pre-tax Income | -3,933 | -2,895 | -3,784 | -3,470 | -2,810 |
| Net Income Continuous | -3,933 | -2,895 | -3,784 | -3,470 | -2,810 |
| Net Income | $-3,933 | $-2,895 | $-3,784 | $-3,470 | $-2,810 |
| EPS Basic Total Ops | -0.66 | -0.46 | -0.64 | -0.58 | -0.67 |
| EPS Basic Continuous Ops | -0.66 | -0.46 | -0.64 | -0.58 | -0.67 |
| EPS Diluted Total Ops | -0.66 | -0.46 | -0.64 | -0.58 | -0.67 |
| EPS Diluted Continuous Ops | -0.66 | -0.46 | -0.64 | -0.58 | -0.67 |
| EPS Diluted Before Non-Recurring Items | -0.66 | -0.49 | -0.64 | -0.58 | -0.67 |
| EBITDA(a) | $-4,080 | $-3,221 | $-4,092 | $-3,842 | $-3,144 |